CD86 and myasthenia gravis: Furthermore, immunofluorescence showed a significant decrease in CD206 expression (a marker of M2‐like MG) accompanied by unregulated CD86 (a feature of M1‐like MG) in APP/PS1 mice along with Iba‐1 over‐expression (Figure 2C).